ライフサイエンスコーパス: lymph node

1 ciated with a 10% risk of missing a positive lymph node.

2 eactive T cells in the spleen and pancreatic lymph node.

3 mulated equally in the recipient mediastinal lymph node.

4 re may function as a kidney-specific type of lymph node.

5 the event of bacterial dissemination to the lymph node.

6 80 cases, SLN biopsy resulted in a positive lymph node.

7 (hypoxia) such as in the liver, spleen, and lymph nodes.

8 F(+) CD11b(hi) NK cells expanded in draining lymph nodes.

9 (local or non-local) or spread to airways or lymph nodes.

10 to increase naive T cell trafficking to the lymph nodes.

11 ing blood, bone marrow, spleen, and draining lymph nodes.

12 equency in islet infiltration and pancreatic lymph nodes.

13 ood, spleen, bronchoalveolar lavage and lung lymph nodes.

14 opulation which is expanded in the blood and lymph nodes.

15 s of treatment response, is approximately 25 lymph nodes.

16 btype interacting with DCs in mouse draining lymph nodes.

17 ion in the lung, independent of the draining lymph nodes.

18 tients with negative (pN0) or positive (pN1) lymph nodes.

19 bound form of the CD40L by CD4(+) T cells in lymph nodes.

20 ablished, TIDC did not migrate into sentinel lymph nodes.

21 rry the bacteria through successive draining lymph nodes.

22 eptors (R) in vitro and in inflamed draining lymph nodes.

23 mented T cell infiltration in tumor-draining lymph nodes.

24 revealed a similar gene signature of TLS and lymph nodes.

25 essed between primary INS and INS-metastatic lymph nodes.

26 rgery, including identification of cancer in lymph nodes.

27 ction in CD4(+) T cell numbers in mesenteric lymph nodes.

28 ofiled for immune responses in the blood and lymph nodes.

29 elevated in Tregs and Bregs of the lal(-/-) lymph nodes.

30 lso enabled identification of tumor cells in lymph nodes.

31 n the levels of NK cells in tonsils and oral lymph nodes.

32 asia, and lymphocyte depletion of spleen and lymph nodes.

33 tic cells and T-cell priming in the draining lymph nodes.

34 tion of both Treg and Th17 cells in cervical lymph nodes.

35 ficient to activate the angiogenic switch in lymph nodes.

36 mous cell carcinoma (SCC), and more positive lymph nodes.

37 in interstitial fluid into the deep-cervical lymph nodes.

38 uces Treg and Breg elevation in the lal(-/-) lymph nodes.

39 lung, liver, and brain, but not for bone or lymph nodes.

40 ed the highest-contrast PET images of target lymph nodes.

41 mproved immune cell infiltration in draining lymph nodes.

42 cy, and it is useful in identifying sentinel lymph nodes.

43 dritic cell IL-27 production in the draining lymph node 12 h after s.c. vaccination directly correlat

44 g (33 patients), peritoneum (32), and portal lymph nodes (14).

45 tary pulmonary nodule (5.2%-14.4%), enlarged lymph nodes (3.7%-9.0%), hyperhidrosis (<2%), and erythe

46 us adenocarcinoma, P < 0.001), removing < 12 lymph nodes (36.5% vs. 26.1% >=12, P < 0.001), community

47 gher sensitivity than CT or (18)F-FDG PET in lymph nodes (92.4% vs. 69.7% and 89.4%, respectively) an

48 Tumor grading, number of positive lymph nodes, a context of intraductal papillary mucinous

49 hort vascular segments displaying peripheral lymph node addressin, and the extravasation of lymphocyt

50 However, colonization of neither draining lymph nodes after IN infection nor the spleen after intr

51 r patients with T1-2 tumors and 1-3 positive lymph nodes after undergoing PMRT.

52 DWI signal less than that in endometrium or lymph nodes allowed readers to confidently diagnose as b

53 Axillary lymph nodes (ALNs) are the regions where BC cells first

54 is a delay in neutrophil recruitment to the lymph node and a reduction in swarm formation following

55 nd follicular helper T cells in the draining lymph node and Ag-specific Th1 and Th17 cells in the spl

56 Thus, lymph node and distant metastases develop through fundam

57 patients and associated with tumor staging, lymph node and distant metastasis.

58 letion of migDC2 reduces the amount of Ag in lymph node and the development of IFNgamma, IL-4 and IL-

59 e DC population in the heart and mediastinal lymph nodes and analyzed long-term cardiac immunopatholo

60 ored the Th17 and Treg content in mesenteric lymph nodes and aorta.

61 itic cells migrating to mediastinal draining lymph nodes and bearing migratory and immunoregulatory m

62 CD4(+) T cell counts in both the mesenteric lymph nodes and colon.

63 mmed-death-ligand-1) in spinal cord-draining lymph nodes and decreases the number of T helper 17 cell

64 a L-selectin and high endothelial venules in lymph nodes and demonstrates how the presence of neutrop

65 o, these memory cells preferentially home to lymph nodes and display rapid proliferation and effector

66 nfection site, transiting through sequential lymph nodes and efferent lymphatic vessels to enter the

67 17 cells rapidly proliferate within neonatal lymph nodes and gut, where, upon entry, they upregulate

68 In the pelvis, (18)F-DCFPyL depicted more lymph nodes and improved positive predictive value and s

69 uces Treg and Breg elevation in the lal(-/-) lymph nodes and improves human cancer cell rejection.

70 ells with reduced effector capacity populate lymph nodes and intestines and exhibit tissue-resident s

71 e aspiration to serially sample the draining lymph nodes and investigate the dynamics and specificity

72 rofile transcriptomes of BEC from peripheral lymph nodes and map phenotypes to the vasculature.

73 In contrast to the lymph nodes and mucosal lymphoid tissues with well-defin

74 g chemokine-mediated T cell trafficking into lymph nodes and PDK1-dependent soluble Ag uptake, costim

75 Central memory T (T(CM)) cells patrol lymph nodes and perform conventional memory responses on

76 zed lymphoid tissues, such as the mesenteric lymph nodes and Peyer's patches, as well as in the lamin

77 nd in the MHC-II peptidome of the pancreatic lymph nodes and spleen.

78 g etiology, we examined post mortem thoracic lymph nodes and spleens in acute SARS-CoV-2 infection an

79 ables in histopathologic studies of positive lymph nodes and surgical specimens: size, lymphovascular

80 s drainage can occur directly to mediastinal lymph nodes and there is no interlobar lymphatic flow.

81 omposition, structure, and gene signature as lymph nodes and therefore may function as a kidney-speci

82 compared with control in patients with bone, lymph node, and chest wall/breast/skin metastases at bas

83 ced/MBC for patients with bone, liver, lung, lymph node, and chest wall/breast/skin metastases.

84 49.6% of patients (22 local recurrences, 63 lymph nodes, and 31 distant metastases).

85 tified: 37 prostate bed foci, 208 lesions in lymph nodes, and 42 in distant sites in bones or organs,

86 rior taxane-based therapy, involved axillary lymph nodes, and centrally determined phenotype (basal v

87 est contrast was achieved in primary tumors, lymph nodes, and distant metastases at 1 h after injecti

88 dometriotic lesion, enlarged retroperitoneal lymph nodes, and immune cells infiltration, indicating t

89 ed dendritic cell numbers in the mediastinal lymph nodes, and increased T-helper type 2 (T(H) 2)-cell

90 live T cells from thymus, spleen, pancreatic lymph nodes, and islets before and after diabetes.

91 Biodistribution in normal organs, lymph nodes, and lesions was evaluated.

92 ere determined for the primary tumor, pelvic lymph nodes, and PALNs.

93 We conducted cytokine profiling in tumor, lymph nodes, and serum of animals within the first 24 h

94 n the retina, cervical lymph nodes, inguinal lymph nodes, and spleen.

95 ctor memory T (T(EM)) cells derived from the lymph node appeared to contain provirus that was genetic

96 mechanisms regulating lymphocyte homing into lymph nodes are only partly understood.

97 ively with tumor grading and the presence of lymph node as well as distant metastases and is specific

98 Prominent uptake was seen in multiple normal lymph nodes as early as 2 h after injection, peaking by

99 ) of macrophages isolated from submandibular lymph nodes as observed by flow cytometry.

100 ecipient, Cosmc-null B cells fail to home to lymph nodes as well as non-lymphoid organs.

101 identified transcriptional signatures in the lymph nodes associated with differences in T cell popula

102 gen-induced immune responses in the draining lymph node at lower doses and reduced administration fre

103 ensemble of three-dimensional CNNs detected lymph nodes at a performance nearly comparable to differ

104 nts with T1-2 breast cancer and 1-3 positive lymph nodes at our institution.

105 TAD involves TLN biopsy (TLNB) and sentinel lymph node biopsy (SLNB) and was recently introduced as

106 Sentinel lymph node biopsy is a promising procedure in patients w

107 mmunohistochemical analyses of tissue from a lymph node biopsy; the tissue morphology and antigen exp

108 within the prostate fossa, local and distant lymph nodes, bones, or visceral organs was recorded.

109 ZIKV RNA was detected in lymph nodes but not the ovaries, uterus, cervix, or vagi

110 D lymph nodes (N = 26) compared with control lymph nodes by immunohistochemistry (IHC) for pS6, p4EBP

111 Mediastinal sequelae included lymph node calcification (74%), fibrosing mediastinitis

112 The small population of neutrophils in the lymph node can act as reconnaissance cells to recruit ad

113 cell TGF-beta signalling in tumour-draining lymph nodes, causing reorganization of tumour vasculatur

114 e thus able to alter the subtypes of drugged lymph node cells to improve immunotherapeutic effects.

115 ules and immune cells from CSF into cervical lymph nodes (CLNs).

116 specific CD8(+) T cells in the skin draining lymph nodes compared to a conventional intradermal injec

117 Normal canine pancreas and lymph node control tissues were compared with primary IN

118 k, delivering cargo to specific cells in the lymph node cortex and paracortex is difficult.

119 were also suppressed in pancreatic draining lymph node, demonstrating bystander tolerance at the sit

120 , lamina propria macrophages, and mesenteric lymph node dendritic cells were examined.

121 This was followed by extended pelvic lymph node dissection (ePLND).

122 y tumor and postchemotherapy retroperitoneal lymph node dissection (PC-RPLND) specimen and assess imp

123 ndings with radical prostatectomy and pelvic lymph node dissection (PLND) histopathology findings.

124 e relapse rate after primary retroperitoneal lymph node dissection (RPLND) for patients with patholog

125 ific antigen (PSA) persistence after salvage lymph node dissection (SLND) and pre-procedure and post-

126 sed use of radical prostatectomy with pelvic lymph node dissection for primary management of high-ris

127 ed surgery and discusses its implications in lymph node dissection in primary and recurrent prostate

128 A total of 1,019 patients with complete lymph node dissection of American Joint Committee on Can

129 Twenty HNSCC patients scheduled for lymph node dissection underwent DCE-MRI, dynamic PET, an

130 nt radical prostatectomy and extended pelvic lymph node dissection.

131 Bacteria then traffic to the draining lymph node (dLN) where they replicate to large numbers.

132 caused selective downregulation of LXA(4) in lymph nodes draining the site of immunization, while at

133 cells in the CNS during disease and draining lymph node during priming.

134 Two thirds scanned regional lymph nodes during the follow-up.

135 onchovascular thickening, satellite nodules, lymph node enlargement, and pleural effusion).

136 that at steady state, neutrophils enter the lymph node entirely via L-selectin and actively exit via

137 mphatic vessels connect the primary tumor to lymph nodes, facilitating tumor entry into lymph nodes,

138 ot simply because they transport antigens to lymph nodes for processing by cDC2, as selective deletio

139 potential and requires T cell migration from lymph nodes for therapeutic efficacy.

140 were immunological changes in granulomas and lymph nodes from anti-IL-10-treated animals.

141 For lymph nodes from the external institution, the algorithm

142 their partial depletion in the gut (25%) and lymph nodes (>50%).

143 Tregs from cervical lymph nodes had reduced Foxp3 expression (> 25% MFI loss

144 edure quality (P < 0.05) and total number of lymph nodes harvested (P < 0.001).

145 admission, oncologic outcomes (R0-resection, lymph nodes harvested), and operative times.

146 Therapeutic delivery selectively to lymph nodes has the potential to address a variety of un

147 vated DCs acquiring features compatible with lymph node homing and antigen presentation, but unexpect

148 mmended for patients with 4 or more positive lymph nodes, however, its role in patients with 1-3 posi

149 ition specifically within the tumor-draining lymph node, identifying a potential role for PD-L1 expre

150 of neutrophils at steady state fortifies the lymph node in case of an infection disseminating through

151 PD-L1 expressing dendritic cells within the lymph node in regulation of anti-tumor immune responses.

152 Tracer was found in regional lymph nodes in 100% of patients in 21 of 27 articles and

153 cells and IFN-gamma production in mesenteric lymph nodes, increased expression of Ido1 in the cecum,

154 h peripheral blood and the draining axillary lymph node, indicating significant BCG vaccine-induced i

155 ild-type B cells blocks their migration into lymph nodes, indicating a requirement of sialylated O-gl

156 sfer into and presentation in tumor-draining lymph nodes induce activation of tumor-specific T-lympho

157 lper 17 (Th17) cells in the retina, cervical lymph nodes, inguinal lymph nodes, and spleen.

158 lly partition the primary tumor and involved lymph nodes into subregions (i.e., habitats) based on (1

159 ing criteria: estrogen receptor (ER) status, lymph node invasion, recurrence free survival.

160 tion of smaller cancers with less associated lymph node involvement and a reduction in the rate of in

161 and compare imaging results with the risk of lymph node involvement based on the Roach formula.

162 Microscopic lymph node involvement in patients with PTC is common, b

163 The risk of lymph node involvement was calculated using the Roach fo

164 The extent of lymph node involvement was the strongest predictor of 5Y

165 edema, areola-nipple complex retraction, and lymph-node involvement were associated with recurrence a

166 nvestigated the appearance of intrapulmonary lymph nodes (IPLNs) at CT with pathologic correlation.

167 f androgen deprivation therapy (ADT) and had lymph node irradiation.

168 mphocytic leukemia (CLL) cells cycle between lymph node (LN) and peripheral blood (PB) and display ma

169 The mouse lymph node (LN) can provide a niche to grow metanephric

170 lerance of autoreactive T cells by impairing lymph node (LN) display of peripheral tissue-restricted

171 hocytes begins when tumor antigens reach the lymph node (LN) to stimulate T cells, yet we know little

172 insertion into the most suspicious axillary lymph node (LN) were eligible.

173 sociated with post-ART SIV control in blood, lymph node (LN), and colorectal (RB) biopsy samples comp

174 subsets derived from peripheral blood (PB), lymph node (LN), and gut tissues of 26 participants afte

175 Little is known regarding lymph node (LN)-homing of immune cells via afferent lymp

176 as a decreased number of LC in skin-draining lymph nodes (LN).

177 io of positive lymph nodes to total assessed lymph nodes (LNR) is an indicator of cancer burden in es

178 Lymph nodes (LNs) are strategically positioned at dedica

179 The presence of metastasis in local lymph nodes (LNs) is a key factor influencing choice of

180 NA levels, and in inducible SIV reservoir in lymph nodes (LNs) of morphine administered RMs.

181 nd the three-dimensional context of reactive lymph nodes (LNs).

182 nses at peripheral sites and within draining lymph nodes (LNs).

183 Our results demonstrate the intrinsic lymph node LXA(4) pathway as a significant checkpoint in

184 For patients with involved lymph nodes, lymph node ratio was an independent predict

185 as performed on transcriptomes isolated from lymph nodes, macrodissected TLS from kidneys, and total

186 common iliac (6/16, 38%) and internal iliac lymph node metastases (6/16, 38%).

187 Undetected lymph node metastases (LNMs) underwent immunohistochemic

188 tumor samples, covering the primary tumors, lymph node metastases (LNMs), and liver metastases from

189 ) have a distinct MRI appearance compared to lymph node metastases (mrLNMs).

190 Polyclonal seeding was common in untreated lymph node metastases (n = 17 out of 29, 59%) and distan

191 reast is correlated with absence of axillary lymph node metastases at final pathology (ypN0) in patie

192 ntification of 4 previously unknown lung and lymph node metastases in 2 patients.

193 patients with recurrences to develop lung or lymph node metastases is eightfold (p = 0.056).

194 Lymph node metastases that occur frequently provide site

195 The presence of lymph node metastases was determined by an experienced r

196 Results: Lymph node metastases were present in 18 patients (31.0%

197 Lymph node metastases were present in the pelvis in 42%

198 Lymph node metastases, in contrast, display high levels

199 recurrences have a higher risk for lung and lymph node metastases.

200 h edition; AJCC-7), stage IIIA (at least one lymph node metastasis > 1 mm), IIIB, or IIIC (without in

201 llow-up (P = 0.05), and longer time to first lymph node metastasis (P = 0.04).

202 expression of Zic1 was correlated with more lymph node metastasis and poor outcome of GC patients.

203 s was positively associated with tumor size, lymph node metastasis, and FIGO stage.

204 nt, including growth of invasive cancers and lymph node metastasis.

205 a more advanced primary tumor and SW620 from lymph-node metastasis.

206 ecific alarmins induced their proliferation, lymph node migration, and blood dissemination, thus syst

207 DCs of mesenteric lymph nodes (MLN) and joint regional lymph nodes (RLN) w

208 l-length viral DNA from peripheral blood and lymph node mononuclear cells (PBMC and LNMC) during ART

209 Presence of malignant regional lymph nodes (MRLNs) precludes curative oncological resec

210 creased in the interfollicular space of iMCD lymph nodes (N = 26) compared with control lymph nodes b

211 Median age was 49 years, 55.9% were lymph node negative, 73.9% had a basal phenotype, and 67

212 ability to recruit additional neutrophils by lymph node neutrophils is initiated by LTB4.

213 entering or distributing within the draining lymph node of ectromelia virus (ECTV)-infected mice or a

214 -mediated premetastatic niche created in the lymph node of TRL-positive patients misleads 18F-FDG-PET

215 revealed increased SIV RNA expression in the lymph nodes of macaques and robust induction of HIV in a

216 MC-derived IL-13 acted on DCs from draining lymph nodes of OVA-sensitized skin to selectively suppre

217 ucing CCR6(+)T cells were highly abundant in lymph nodes of SLE patients, and colocalized with B cell

218 ritic cells (DCs) purified from the draining lymph nodes of tape-stripped and ovalbumin (OVA)-sensiti

219 uced the concentration of IL-12 and IL-17 in lymph nodes of treated and contralateral tumors suggesti

220 nes, nanovaccines provide improved access to lymph nodes, optimal packing and presentation of antigen

221 ve MRI criteria for malignancy were enlarged lymph nodes or peritoneal implants, high DWI signal grea

222 s with PTLD in the Waldeyer's ring, cervical lymph nodes, or small bowel with either nondestructive o

223 86 and .006, respectively), and the draining lymph nodes (P = .02).

224 ntly invasive (P < .001), had fewer positive lymph nodes (P = .04) and distant metastases (P = .01),

225 vanced cervical cancer (LACC) and paraaortic lymph node (PALN) involvement.

226 systems, including the lungs, spleen, liver, lymph nodes, pancreas and extrahepatic bile duct with po

227 with significantly lower rates of pathologic lymph nodes, perineural invasion, and venous invasion.

228 DSC MRI were associated with local malignant lymph nodes (pN status).

229 In lymph node-positive, triple-negative breast cancer (TNBC

230 eased by an average of 36%, whereas sentinel lymph-node procedures decreased by 45%, lung scans by 56

231 For patients with involved lymph nodes, lymph node ratio was an independent predictor of progres

232 uencies of memory Th17 cells in the draining lymph nodes relative to young mice.

233 ever, its role in patients with 1-3 positive lymph nodes remains unclear.

234 xamination of the primary tumor and draining lymph nodes) require the infrastructure and expertise of

235 umors transport antigens and share them with lymph node resident DCs through cross-presentation.

236 that metastatic streptococci within infected lymph nodes resist and subvert clearance by phagocytes,

237 Ga-PSMA-11 for ganglia, bone, and unspecific lymph nodes, respectively).

238 tion of lung dendritic cells to the draining lymph nodes, resulting in greater numbers of virus-speci

239 atics and the size-restrictive nature of the lymph node reticular network, delivering cargo to specif

240 ene profiles of whole kidney, renal TLS, and lymph nodes revealed a similar gene signature of TLS and

241 compared with primary INS and INS-metastatic lymph nodes, revealing more than 3,000 genes differentia

242 enteric lymph nodes (MLN) and joint regional lymph nodes (RLN) were analyzed in TNFRp55(-/-) and wild

243 timulation assays in colon, tonsil, and oral lymph node samples.

244 Regional lymph node scanning was routinely done by 14/23 (61%) an

245 ing in reduced LC migration to skin-draining lymph nodes (sdLNs) and defective skin tolerance inducti

246 three settings: in vitro wound healing, live lymph node sections and a live tumor microenvironment.

247 Tonsils are the lymph nodes serving the upper respiratory tract, acting

248 ls and their recruitment to the CNS-draining lymph nodes, sparing their liver-draining counterparts.

249 ssues known to be viral reservoirs including lymph nodes, spleen, bone marrow, and brain among others

250 nces in MRI parameters and relationship with lymph node stage.

251 treatment TRL misleads 18F-FDG-PET/CT during lymph node staging in gynecological malignancies.

252 should include D2 lymphadenectomy (including lymph node stations in the perigastric mesentery and alo

253 ter RARP (P = 0.004) and positive pathologic lymph node status (P = 0.006) were independent predictor

254 SA levels after RARP and positive pathologic lymph node status were significantly associated with met

255 fication factors were breast cancer therapy, lymph node status, hormone receptor and HER2 status, age

256 Lymph node stromal cells (LNSC) are essential for provid

257 be programmed, allowing access to different lymph node structures and therefore specific lymphocyte

258 ion of dendritic cells in the tumor-draining lymph nodes, subsequently initiating T cell-mediated imm

259 ing metastasis and performing imaging-guided lymph node surgery is challenging.

260 o lymph nodes, facilitating tumor entry into lymph nodes, systemic circulation, and metastasis.

261 eriments revealed that while Notch-deficient lymph node Th2 cells established competence for lung mig

262 each vastly more immune cells throughout the lymph node than either the particles or free compounds a

263 gher levels of intra-lesion heterogeneity in lymph node than in distant metastases.

264 (18)F-DCFPyL depicted more pelvic lymph nodes than did MRI (128 vs 23 nodes).

265 In the lal(-/-) lymph nodes, the percentages of both T- and B-regulatory

266 al role in trafficking allergens to regional lymph nodes through activating dendritic cells.

267 es analysed in humanized mice, including the lymph nodes, thymus, bone marrow, liver and lung.

268 Lymph-node tissue from axilla was positive for the long-

269 ne sequencing; lamina propria and mesenteric lymph node tissues were analyzed by RNA sequencing and f

270 justed for age, stage, and histology, pelvic lymph node TLG, PALN TLG, and PALN SUV(max) were signifi

271 ility and accuracy of non-radioactive target lymph node (TLN) biopsy and targeted axillary dissection

272 We hypothesized that the ratio of positive lymph nodes to total assessed lymph nodes (LNR) is an in

273 terization of immune cells in the mesenteric lymph nodes, to delineate colonic immune niches at stead

274 gic surgical options, including vascularized lymph node transplant (VLNT) and lymphovenous bypass (LV

275 eleration of naive T cell recruitment to the lymph nodes upon inflammation.

276 rane-bound protein in HNSCC cells of invaded lymph nodes, vascular endothelial growth factor-A (VEGF-

277 The precise contribution of the lymph node vasculature to the regulation of this process

278 d subsequently migrate toward the mesenteric lymph nodes via the mesenteric lymphatic capillaries.

279 The median number of examined lymph nodes was 21 after McKeown TMIE and 25 after Ivor

280 The median number of involved lymph nodes was 3 (range, 1-37 nodes), and the median si

281 Removing 25 to 30 lymph nodes was associated with a 10% risk of missing a

282 f Gd-DOTA to submandibular and deep cervical lymph nodes was demonstrated as 25-50% T1 reductions in

283 A lower number of excised lymph nodes was independently associated with worse OS a

284 (P = 0.089), whereas involvement of thoracic lymph nodes was significantly associated with an adverse

285 Within lymph nodes, we observed augmented GC B cell responses a

286 Histologically positive lymph nodes were associated with a greater percentage of

287 Lymph nodes were detected in 23 patients and bone metast

288 Lymph nodes were segmented and annotated as ENE-positive

289 ), PS, and K(trans) values of the metastatic lymph nodes were significantly lower (p = <0.05) than th

290 Pattern analysis showed that pelvic lymph nodes were the most common site of recurrence, and

291 mple Ags in the periphery and migrate to the lymph node where they activate T cells.

292 ce germinal centre reactions in the draining lymph nodes, where diversification and maturation of rec

293 lay peripheral tissue-restricted antigens in lymph nodes, which impaired their capacity to purge and

294 s' age at diagnosis or information regarding lymph nodes, which were employed to build various novel

295 r patients with T1-2 tumors and 1-3 positive lymph nodes, who underwent mastectomy from 2004 to 2015.

296 sponse in primary tumors and in the axillary lymph nodes with metastasis (ALN(+)) in breast cancer (B

297 ling, and increased seeding to the liver and lymph node work as interconnected pathways, leading to t

298 rbidity, mortality, radicality of resection, lymph node yield and 3-year conditional survival did not

299 , downstages patients, and decreases overall lymph node yields (LNY) compared to initial surgical res

300 5% in the submucosa (ypT1b) and 6.4% only in lymph nodes (ypT0N+).